Virtual Library

 x 
My Library Virtual Library FAQ

Start Your Search

S. Yokota



Author of

  • +

    Poster Session (ID 8)

    • Event: ACLC 2018
    • Type: Poster Session
    • Track:
    • Presentations: 1
    • Moderators:
    • Coordinates: 11/07/2018, 00:00 - 00:00, Poster Hall
    • +

      P080 - Efficacy and Safety of Docetaxel Plus Ramucirumab: A Consecutive Analysis of 68 Patients with Advanced NSCLC (ID 214)

      00:00 - 00:00  |  Author(s): S. Yokota

      • Abstract

      Background:
      Docetaxel plus ramucirumab (DTX+RAM) prolongs survival in patients with non-small cell lung cancer (NSCLC) with disease progression after platinum-based therapy. We assessed the efficacy and safety, especially the incidence of febrile neutropenia (FN), in patients who received DTX+RAM.


      Method:
      Consecutive patients who received DTX+RAM between August 2016 and May 2018 were reviewed retrospectively.


      Results:
      A total 68 patients received DTX+RAM. The patients